Market Research Logo

Avacta Group Plc (AVCT) - Product Pipeline Analysis, 2018 Update

Summary

Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an in-clinical blood testing system that delivers ELISA tests. The company offers intellectual property relating to an alternative to antibodies. It develops reagents and diagnostics that are used in affinity chromatography, protein to protein interactions, immunoassay and rapid diagnostic test applications, among others. It has operations in Wetherby, Cambridge and London. Avacta is headquartered in Wetherby, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Avacta Group Plc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


  • Avacta Group Plc Company Overview
    • Avacta Group Plc Company Snapshot
    • Avacta Group Plc Pipeline Products and Ongoing Clinical Trials Overview
      • Table Avacta Group Plc Pipeline Products and Ongoing Clinical Trials Overview
      • Table Avacta Group Plc Pipeline Products by Equipment Type
      • Table Figure 1: Avacta Group Plc Pipeline Products by Equipment Type
      • Table Avacta Group Plc Pipeline Products by Indication
  • Avacta Group Plc – Pipeline Analysis Overview
    • Avacta Group Plc - Key Facts
      • Table Avacta Group Plc, Key Facts
    • Avacta Group Plc - Major Products and Services
      • Table Avacta Group Plc, Major Products and Services
    • Avacta Group Plc Pipeline Products by Development Stage
      • Table Figure 2: Avacta Group Plc Pipeline Products by Development Stage
      • Table Avacta Group Plc Number of Pipeline Products by Development Stage
      • Table Avacta Group Plc Pipeline Products Summary by Development Stage
  • Avacta Group Plc Pipeline Products Overview
    • Depression Test
      • Depression Test Product Overview
        • Table Depression Test - Product Status
        • Table Depression Test - Product Description
    • Diagnostic Assay - Alzheimer's Disease
      • Diagnostic Assay - Alzheimer's Disease Product Overview
        • Table Diagnostic Assay - Alzheimer's Disease - Product Status
        • Table Diagnostic Assay - Alzheimer's Disease - Product Description
    • Diagnostic Test - ADHD
      • Diagnostic Test - ADHD Product Overview
        • Table Diagnostic Test - ADHD - Product Status
        • Table Diagnostic Test - ADHD - Product Description
    • Diagnostic Test - Bipolar Disorder
      • Diagnostic Test - Bipolar Disorder Product Overview
        • Table Diagnostic Test - Bipolar Disorder - Product Status
        • Table Diagnostic Test - Bipolar Disorder - Product Description
    • Point-Of-Care Diagnostic Test - Zika Virus
      • Point-Of-Care Diagnostic Test - Zika Virus Product Overview
        • Table Point-Of-Care Diagnostic Test - Zika Virus - Product Status
        • Table Point-Of-Care Diagnostic Test - Zika Virus - Product Description
    • Portable Pathogen Detection System
      • Portable Pathogen Detection System Product Overview
        • Table Portable Pathogen Detection System - Product Status
        • Table Portable Pathogen Detection System - Product Description
    • Rapid Diagnostic Test - Bacterial Strains
      • Rapid Diagnostic Test - Bacterial Strains Product Overview
        • Table Rapid Diagnostic Test - Bacterial Strains - Product Status
        • Table Rapid Diagnostic Test - Bacterial Strains - Product Description
    • Rapid Diagnostic Test - Infectious Diseases
      • Rapid Diagnostic Test - Infectious Diseases Product Overview
        • Table Rapid Diagnostic Test - Infectious Diseases - Product Status
        • Table Rapid Diagnostic Test - Infectious Diseases - Product Description
    • Schizophrenia Response Test
      • Schizophrenia Response Test Product Overview
        • Table Schizophrenia Response Test - Product Status
        • Table Schizophrenia Response Test - Product Description
    • Schizophrenia Side Effects Test
      • Schizophrenia Side Effects Test Product Overview
        • Table Schizophrenia Side Effects Test - Product Status
        • Table Schizophrenia Side Effects Test - Product Description
  • Avacta Group Plc - Key Competitors
  • Avacta Group Plc - Key Employees
    • Table Avacta Group Plc, Key Employees
  • Avacta Group Plc - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
      • Table Avacta Group Plc, Other Locations
      • Table Avacta Group Plc, Subsidiaries
  • Recent Developments
    • Avacta Group Plc, Recent Developments
      • Jun 11, 2018: Avacta Group Appointments Dr Eliot Forster As Non-Executive Chairman
      • Apr 16, 2018: Avacta Group Announces Interim Results for the Period Ended 31 January 2018
      • Mar 29, 2018: Avacta Group Announces Directorate Change
      • Jan 18, 2018: Avacta Group: AGM Business Update and Notice of Results
      • Dec 10, 2017: Avacta to Present Customer Data at Major US Conference
      • Nov 15, 2017: Covance to Present Affimer Data at European Conference
      • Oct 04, 2017: Avacta Group: Preliminary Results for the Year Ending 31 July 2017
      • Oct 02, 2017: Avacta Establishes US Business Development Team
      • Aug 07, 2017: Avacta Group: Trading Update and Notice of Results
      • May 10, 2017: Avacta Group: Key Affimer patent to be granted in China
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report